Abstract
The magnetic resonance imaging-based Rotterdam European Randomized Study of Screening for Prostate Cancer (MRI-ERSPC) risk calculators include age and Prostate Imaging Reporting and Data System as parameters, and predict (Gleason ≥3 + 4) prostate cancer in transrectal ultrasound-guided systematic biopsy and MRI-targeted biopsy. The MRI-ERSPC risk calculator could help avoid one-third of biopsies following MRI in previously biopsied men.
Author supplied keywords
Cite
CITATION STYLE
Alberts, A. R., Roobol, M. J., Verbeek, J. F. M., Schoots, I. G., Chiu, P. K., Osses, D. F., … Arsov, C. (2019). Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators. European Urology, 75(2), 310–318. https://doi.org/10.1016/j.eururo.2018.07.031
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
